Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2026-07-01 16:10:10 ET · period of report 2026-06-29 · accession 0001213900-26-074238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-01 16:10 | 2026-06-29 | TARA | Shefferman Jesse | CEO, Pres, Dir | M - OptEx | $1.91 | +215.7K | 937.5K | +30% | +$412.0K |
| D | 2026-07-01 16:10 | 2026-06-29 | TARA | Shefferman Jesse | CEO, Pres, Dir | S - Sale+OE | $4.09 | -215.7K | 721.8K | -23% | -$882.2K |
| DM | 2026-07-01 16:10 | 2026-06-30 | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -30.0K | 691.8K | -4% | $0 |
| D | 2026-07-01 16:10 | 2026-06-29 | TARA | Shefferman Jesse | CEO, Pres, Dir | M - OptEx | $0.00 | -215.7K | 141.3K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | M | A | 215,687 | $1.91 | 937,519 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-29 | S | D | 215,687 | $4.09 | 721,832 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.14, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2026-06-30 | G | D | 14,000 | $0.00 | 707,832 | D | — | — | |
| 4 | Common | Common Stock | 2026-06-30 | G | D | 7,000 | $0.00 | 700,832 | D | — | — | |
| 5 | Common | Common Stock | 2026-06-30 | G | D | 4,000 | $0.00 | 696,832 | D | — | — | |
| 6 | Common | Common Stock | 2026-06-30 | G | D | 5,000 | $0.00 | 691,832 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 215,687 | $0.00 | 141,313 | D | $1.91 · — to 2034-01-18 | 215,687 Common Stock | (F4) 25% of the shares underlying the option vested on January 19, 2025 and the remaining shares have vested or will vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's continuous service with the Issuer as of each such date. |